CMPX
COMPASS THERAPEUTICS, INC.NasdaqResearch view
Healthcare · Biological Products, (No Diagnostic Substances) · SEC EDGAR FY 2025-12-31
Price history
Chart: TradingView’s own feed · page prices: 1D EOD🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2025-12-31SectorHealthcare
Income—
Sales$0
Book/sh$1.09
Cash/sh$0.17
Dividend TTM—
Payout—
Employees—
IPO—
Quick Ratio—
Current Ratio15.02
Debt/Eq—
EPS (ttm)$-1.31
EPS this Y-36.5%
EPS past 3/5Y—
Sales past 3/5Y—
EPS Y/Y TTM-36.5%
Sales Y/Y TTM—
Shs Outstand180.09M
ROA—
ROE—
ROIC-44.0%
Gross Margin—
Oper. Margin—
Profit Margin—
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$0
2023
$850,000
2024
$0
2025
Financials — annual
SEC EDGAR · last 3 FY · tap a row to explain it| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | $0 | $850,000 | $0 |
| Gross Profit | — | — | — |
| Operating Income | $-50.4M | $-56.6M | $-72.8M |
| Net Income | $-42.5M | $-49.4M | $-66.5M |
| Diluted EPS | — | — | — |
| Operating Cash Flow | $-40.6M | $-44.9M | $-49.1M |
| Free Cash Flow | $-40.6M | $-44.9M | $-49.2M |
Follow the news. Track the move.
CMPX story timeline
Company updates and connected market context, with the dated price move attached.
1
Stories
0
Direct
COMMUNITY · $CMPX0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.